TFX Teleflex Incorporated

Teleflex Publishes 2nd Annual Global JOIN Impact Report

Teleflex Publishes 2nd Annual Global JOIN Impact Report

The annual report highlights how Teleflex is driving the shift towards a sustainable future through its employee-led JOIN Act with Purpose CSR initiative

WAYNE, Pa., Aug. 18, 2020 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), today announced the publication of its 2nd annual Global JOIN Impact Report. The report outlines the progress the company made in 2019 in the areas of people, environmental sustainability with a focus on pollination, and business programs through its JOIN Act with Purpose initiative. JOIN is Teleflex’s unique way of approaching responsibility powered by its employees.

“I continue to be inspired by the dedication of our employees to act responsibly for the good of our communities, our environment, and those in need. 2019 was no exception,” said Liam Kelly, Chairman, President and CEO. “Our actions across all of Teleflex, including the medical devices we produce, are carried out in support of our Core Values and mission. We also continue to make an impact through the work of The Teleflex Foundation and our Humanitarian Donations Program.”

The theme of ‘Planting with Purpose’ was used across Teleflex’s sites to engage and educate employees about the critical role pollinators play in a sustainable planet. Through volunteering events, employees learned the importance of acting now to improve our conservational efforts and take the necessary steps to ensure we protect our eco-system.

Cam Hicks, Corporate Vice President, Human Resources & Communications said, “Teleflex employees are at the center of everything we do, and because of their efforts, we were able to build on our corporate social responsibility initiatives in 2019. At the local, regional and global levels, thank you for making a difference in the health and quality of people’s lives.”

The Global JOIN Impact Report can be accessed through the home page or investor page of the company’s website .

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular access, interventional cardiology and radiology, anesthesia, emergency medicine, surgical, urology and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit .

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rüsch®, UroLift®, and Weck® – trusted brands united by a common sense of purpose.

Source:

Teleflex Incorporated

Jake Elguicze

Treasurer and Vice President, Investor Relations

610-948-2836

EN
18/08/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Teleflex Incorporated

Teleflex Incorporated - September 2025 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Moody's Ratings revises Teleflex's outlook to stable, affirms Ba1 CFR,...

Moody's Ratings (Moody's) affirmed the ratings of Teleflex Incorporated ("Teleflex") including the Ba1 Corporate Family Rating (CFR), Ba1-PD Probability of Default Rating (PDR) and the Ba2 rating on the senior unsecured notes. The company's Speculative Grade Liquidity Rating (SGL) was unchanged at S...

 PRESS RELEASE

Teleflex Announces Sale of Acute Care, Interventional Urology, and OEM...

Teleflex Announces Sale of Acute Care, Interventional Urology, and OEM Businesses for $2.03 Billion Board of Directors authorizes new $1 billion share repurchase program WAYNE, Pa., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced it has entered into definitive agreements to sell the company’s Acute Care, Interventional Urology and OEM businesses to two buyers, Intersurgical® Ltd with respect to Acute Care and Interventional Urology, and Montagu and Kohlberg with respect to OEM, for a combined total of...

 PRESS RELEASE

Teleflex to Present at the Jefferies Global Healthcare Conference in L...

Teleflex to Present at the Jefferies Global Healthcare Conference in London WAYNE, Pa., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Management of Teleflex Incorporated (NYSE: TFX) is scheduled to speak at the Jefferies Global Healthcare Conference in London on Tuesday, November 18, 2025, at 10:00 a.m. (GMT). A live audio webcast of the conference presentation will be available on the investor section of the Teleflex website at . About Teleflex Incorporated As a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people’s lives. Through ...

 PRESS RELEASE

Teleflex Announces Quarterly Dividend

Teleflex Announces Quarterly Dividend WAYNE, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable December 15, 2025, to shareholders of record at the close of business on November 14, 2025. About Teleflex Incorporated As a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people’s lives. Through our vision to become the most trusted partner in health...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch